IP Library Granted Patent US 7,795,493
Granted Patent B2
US 7,795,493 · App. 10/646,970 · Granted Sep 14, 2010

Porcine animals lacking any expression of functional alpha 1, 3 galactosyltransferase

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,795,493
App. No.
10/646,970
Granted
Sep 14, 2010
Kind
B2
Abstract

The present invention is a porcine animal, tissue, organ, cells and cell lines, which lack any expression of functional alpha 1,3 galactosyltransferase (alpha1,3GT). These animals, tissues, organs and cells can be used in xenotransplantation and for other medical purposes.

Claims (8)

1. A method for the production of a pig that lacks any expression of functional alpha-1,3 galactosyltransferase (α-1,3 GT) comprising: breeding a male pig heterozygous for an inactivation of the alpha-1,3 GT gene with a female pig heterozygous for an inactivation of the α-1,3 GT gene, wherein one or both pigs are heterozygous due to the presence of a point mutation in an allele of the α-1,3 GT gene, wherein the point mutation is a T-to-G point mutation at the second base of exon 9 of the α-1,3 GT gene or a point mutation induced or produced by a genetic modification in the α-1,3 GT gene.

2. The method of claim 1 , wherein the point mutation is a T-to-G point mutation at the second base of exon 9 of the α-1,3 GT gene.

3. The method of claim 1 , wherein a male pig that contains a T-to-G point mutation at the second base of exon 9 of the α-1,3 GT gene is bred with a female pig that contains a T-to-G point mutation at the second base of exon 9 of the α-1,3 GT gene.

4. The method of claim 1 , wherein at least one of the male or female pigs comprises at least one allele of an α-1,3 GT gene that is inactivated via a genetic targeting event.

5. The method of claim 1 , further comprising breeding together the pigs that lack any expression of functional α-1,3 GT to produce a herd of pigs that lack any expression of functional α-1,3 GT.

6. A non-naturally occurring pig produced according to the method of claim 1 , 2 , 3 , 4 or 5 .

7. A cell, tissue, or organ obtained from the pig of claim 6 .

8. The cell, tissue or organ of claim 7 wherein at least one allele of an α-1,3 GT gene is inactivated via a genetic targeting event.

Assignments (4)
RELEASE OF PATENT SECURITY AGREEMENT RECORDED AT REEL 025649/FRAME 0609 Recorded Jul 12, 2011
From: LIFECELL CORPORATION
To: REVIVICOR, INC.
Reel/Frame 026578/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2011
From: AYARES, DAVID L.
To: REVIVICOR, INC.
Reel/Frame 026439/0295 →
SECURITY AGREEMENT Recorded Jan 18, 2011
From: REVIVICOR, INC.
To: LIFECELL CORPORATION
Reel/Frame 025649/0609 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2004
From: PHELPS, CAROL J.
To: REVIVICOR, INC.
Reel/Frame 014233/0538 →